The marketing around GLP-1 boosting supplements has moved much faster than the science, and many consumers now assume these products offer effects comparable to prescription GLP-1 receptor agonists which simply isnt the case
-20C, 1 month (sealed storage, away from moisture and light)
These results indicate that the loss of cellular glutathione and increase in oxidative stress alters vitamin D metabolism genes and vitamin D receptors, which can predispose the body to 25(OH)VD 3 deficiency
In consideration of the dual roles of GLP-1RAs in hypoglycemic effects and preventing CVD among T2DM patients, we reviewed the cardiovascular effects and molecular mechanisms of GLP-1RAs in CVOTs, animal models and cultured cells, and discuss how these findings transform pharmacotherapies for T2DM, and even expand the indication of this important category of anti-diabetic drugs to CVD patients without diabetes
Without rigorous, peer-reviewed clinical trials, the long-term behaviour of these substances within the body remains less clear than that of MHRA-approved medications
